Celcuity Inc. (NASDAQ:CELC) will be hosting a conference call at 4:30 PM eastern time on 10th August 2020, to discuss its 2Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.celcuity.com
Earnings Expectation
Celcuity Inc. is reporting second quarter earnings results on Monday 10th August 2020, after market close. The consensus estimates from Thomson Reuters are loss of $ 0.18 per share. For the full year, analysts predict loss of $ 0.72 per share.
Celcuity Inc., a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the clinical outcomes of cancer patients treated with targeted therapies in the United States. The companys CELx diagnostic platform uses a patients living tumor cells to identify the specific abnormal cellular process driving a patients cancer and the targeted therapy that treats it. It is developing CELx HSF test to diagnose two new sub-types of HER2-negative breast cancer.
